Remove Immunity Remove Insurance Coverage and Processing Remove Pharmaceutical Manufacturing
article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Credit: luchschenF /Shutterstock.

article thumbnail

Pharmacy Policy Updates for June 2025

Pharmacy Times

The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes.

article thumbnail

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Don’t let policy changes catch you off guard.